Cancer

Factors ID'd for MAPK treatment outcome in melanoma

(HealthDay)—For patients with metastatic melanoma treated with mitogen-activated protein kinase (MAPK) inhibitors, gender, serum lactate dehydrogenase (LDH), BRAF genotype, and primary melanoma ulceration status are independent ...

Aug 03, 2015
popularity10 comments 0